Life Sciences Archive » July, 2008

Life Sciences - July, 2008

172 articles

• FDA Orders Stronger Warn Labels For Anemia Drugs
• Judge Knocks Down Schwarz's Claims In Miralex Case
• 2nd Circ. Cuts NYSE Traders Loose
• FDA Warns Baxter On Hemophilia Drug Promotion
• Class Certification Denied In Express Scripts Suit
• Ariz. Court Validates Bard's Graft Patent
• Abraxis Fails To Nix Naropin Suit Antitrust Claims
• AstraZeneca Files 5th Suit Over Generic Seroquel
• Abbott Settles HIV Antitrust Suit With Indirect Buyers
• Sepracor Suits Over Planned Generic Xyzal Pile Up
• Teva Settles Coreg Suit Against Dr. Reddy's
• Riegel V. Medtronic: Better Off Without It?
• Fed. Circ. Sides With Sanofi In Patent Spat With Novo
• Buchanan Ingersoll Disqualified From Ritalin Suit
• FDA Seizes $24M In Unapproved Drugs From KV
• Judge Rejects New Notice For Digitek Patients
• Drug Cos. Win Big With Pass-On Defense
• German Court OKs Generic Plavix, Cos. To Appeal
• Judge OKs Nellson's Disclosure Statement
• Endo Hits Impax With 3rd Suit Over Painkiller
• 2nd Circ. Affirms FDA Injunction Decision
• Novartis Sues Teva Over Premature ANDA Letters
• Judge Tosses Preempted Claims From Aredia Suits
• Melnyk Drops Biovail Proxy Bid, For Now
• Seven Patents Dropped From GE Patent Battle
• Payout Rates Slashed For Litigators In Medtronic MDL
• Stent Inventor Sues Abbott For Infringement
• Lawyers In Guidant Case Ask For Higher Fee
• EU Product Liability Directive's Statute Of Limitations
• LecTec Sticks J&J, Others With Medical Patch Suit
• PRP Breached Duty To Verex Shareholders: Jury
• Opponents Of Gene Patents Fight On
• Judge Dismisses Ortho-McNeil From One AWP Claim
• FTC Launches Formal Investigation Into Immucor
• Biovail Dodges Antitrust Class Actions Over Tiazac
• Judge Cites Cert Grant In Keeping Lexapro Cases Alive
• Shire Sues Actavis Over Carbatrol ANDA
• Patent Injunctions After EBay
• Regulatory And Govt. Affairs Practice: WilmerHale
• Employment Practice: Jones Day
• AstraZeneca Sues Mylan Over Entocort ANDA
• Lawyers Debate Value Of 'Lone Pine' Orders
• Feds Seize Erectile Dysfunction Drugs
• Shareholder Sues Roche, Genentech Over $43.7B Deal
• State Courts Embrace On-Camera Culture
• Cephalon Sues Barr Over Generic Fentora
• Suit Alleges Teva's Pergolide Damaged Heart Valves
• Regulators Conclude Merck's Gardasil Is Safe
• Sanofi Can't Subpoena Employers In Gender Suit
• On Biotech Hot Streak, Roche Picks Up Arius
• Amerigroup Settles Discrimination Suit For $234M
• Hire Sheet: Law Firms Hired For Major IP Litigation
• GSK Snags Former FDA General Counsel Dan Troy
• Baxter Wins Judgment In Failure-To-Warn Case
• Hire Sheet: Law Firms Hired For Major IP Litigation
• USPTO Asks Fed. Circ. To Reverse Ruling In Tafas Case
• FDA Warns Anika About 'Adulterated' Devices
• Biota, GSK Settle Relenza Marketing Suit For $19.5M
• New Study Adds Vytorin Woes For Merck, Schering
• Regulatory Practice: Fish & Richardson
• Judge Rejects KV Sanctions Bid In Ritalin ANDA Suit
• Portable Ultrasound Makers Settle Patent Dispute
• Impax's Flomax ANDA Triggers Patent Suit
• Boston, Medtronic Agree To Slash Damages By $64M
• Fed. Circ. Upholds Eisai's Aciphex Patent
• W.L. Gore Says Medtronic Patents Are Invalid
• Regulators To Take Close Look At Big Pharma Deals
• Leiner Files Plan With Committee's OK
• Paxil Preemption Ruling Reversed In Indiana
• Ortho V. Mylan: Key Ruling For 2 Statutory Provisions
• View Of Swamped USPTO Cutting Corners Challenged
• Jury Clears J&J, Motrin For Girl's Blindness
• House To Probe FDA Knowledge Of Ranbaxy Fraud
• Merck's Vioxx Payouts To Begin In August
• Product Liability Practice: DLA Piper
• KV Sues Breckenridge Over Supplement Patent
• Hire Sheet: Law Firms Hired For Major IP Litigation
• Sanofi Stalls Generic Plavix Launch In Germany
• IP Practice: Akin Gump
• DEA's New Proposed Regulations For E-Prescribing
• New Mexico Rebuked Over Discovery In Zyprexa Case
• S.C. Mayor Settles Insider Trading Suit With SEC
• Fenwick Life Sciences Partner Jumps To Reed Smith
• Wyeth, Impax Settle Effexor Patent Dispute
• Advanced Bionics Pays $1.1M To Settle With FDA
• Wyeth Reverses Course, Settles Prempro Suit
• SmithKline Beecham Sued For Generic Flonase Delay
• N.J. Packagers Are Link In Acutrim Liability Chain
• Health Practice: Hogan & Hartson
• Hire Sheet: Law Firms Hired For Major IP Litigation
• Fed. Circ. Rules Apotex's Fosamax Appeal Moot
• Judge Orders New Biovail Shareholder Meeting
• Katten Hires Former Ev3 Patent Counsel
• Cos. Settle Dutch Probe Into Oil-For-Food For €1.3M
• IP Practice: WilmerHale
• Wilson Sonsini Adds Veteran Litigator In New York
• New Study Hints At More Fosamax Problems
• Abbott, Hospira To Face Trial In ERISA Class Action
• FDA Warns Avastin May Cause Anemia
• Judge Gives Biotech Co. Shareholders 2nd Chance
• Hire Sheet: Law Firms Hired For Major IP Litigation
• Fed. Circuit Remands Stent Case Over 'Ambiguity'
• Post-KSR Case Law: The Sky Is Not Falling
• By-Pass Sues Abbott Over Vascular Repair Patent
• N.J. Court Dismisses Hormone Therapy Lawsuit
• Hire Sheet: Law Firms Hired For Major IP Litigation
• Amgen Agrees To $200M Settlement Of Antitrust Suit
• Judge Partly Reverses $250M Verdict For Medtronic
• Sides Bicker Over Bifurcation In Mirapex Case
• IP Practice: Hogan & Hartson
• AstraZeneca Files Ninth Suit Over Crestor Patent
• Firm Wants Higher Contingency Fee In Guidant MDL
• Ranbaxy Denies DOJ Allegations Over Audits
• Judge Finalizes Last Warner Chilcott Settlement
• The Last Word On Drug Preemption?
• Forklift Operator Avoids Jail In Insider Trading Scam
• Hire Sheet: Law Firms Hired For Major IP Litigation
• Transkaryotic Ex-CEO Settles SEC Suit For $1.2M
• Roche, Ranbaxy Patent Fight Can Go To Trial
• Emergent Sues Protein Sciences Over Failed Deal
• Cases Added To MDL Over Tainted Heparin
• Actavis Hit With Class Action Over Digitek
• Suit Claims Botox Caused Injuries, Deaths
• Abbott Labs Strikes Again Over Depakote ER
• House Of Lords Validates Angiotech's Stent Patent
• Health Practice: McDermott, Will & Emery
• Corepharma Counterclaim Restored To Carbatrol Suit
• M&A Practice: Duane Morris
• Pharmaceutical Industry Revises Code Of Conduct
• Boston Scientific Bid For New Stent Trial Rejected
• Celgene Sues Barr Again Over Cancer Drug
• Biolitec Attacks VNUS' Laser Treatment Patents
• IP Practice: White & Case
• Judge Lifts Stay Of Counterclaims In Ofloxacin Case
• No Proven Links Between Eczema Drug, Cancer: Judge
• Apotex Acular ANDA Infringes Roche: Fed. Circ.
• Judge Tosses $27M Award In Prempro Case
• Pfizer Forgoes Fees To Close Accupril Suit
• Competition Practice: McDermott Will & Emery
• Karl Storz Sues FemSuite Over Endoscope Patent
• Abbott Loses Appeal Bid In HIV Drug Litigation
• Molecular Samples Tester Sued Over Assay Patents
• FDA Urges Warning For Cipro, Other Antimicrobials
• Pillsbury Lures Partner From Schulte Roth
• Bristol-Myers Agrees To Clean Air Act Upgrades
• Anheuser Takes InBev To Court Over Takeover Bid
• InBev Moves To Dislodge Anheuser Board
• 3rd Circuit Affirms Dismissal Of Savient Class Action
• Judge Inclined To OK Zyprexa Class, Urges Settling
• Shire Sues Apotex, Nostrum Over Carbatrol ANDAs
• The Shifting Landscape Of Declaratory Judgment Law
• Time For A New Look At Antitrust Penalties
• Sheppard Adds Two IP Litigators To Its Ranks
• Panel Recommends More Testing for Diabetes Drugs
• Daiichi Sankyo's Patent Suits V. Mylan Combined
• Eli Lilly Drops Glenmark In $500M ADHD Drug Suit
• Pfizer Employee Avoids Prison in Embezzlement Case
• VNUS Sues Three More Rivals Over Laser Treatment
• Drugmakers To Appeal $114M Verdict In AWP Case
• IP Practice: Holland & Knight
• Jury Lets One Fen-Phen Lawyer Off The Hook
• Inequitable Conduct Claim Nixed In Seroquel Suit
• Bone Fusing Products Pose Risk, FDA Says
• Pfizer Wins Dismissal Of 4 Claims From Celebrex Suit
• Patent Litigator Leaves Latham For Kaye Scholer
• CORRECTED: Cardio Access Expands Catheter Patent Suit
• Plaintiffs Battle For Lead Role In Vytorin ERISA Suit
• AstraZeneca Sues To Protect Accolate
• Iraq Sues 93 Over Oil-For-Food Corruption
• VA Official Pleads Guilty To Accepting Kickbacks
• Bavarian Nordic Sues Oxford BioMedica Over Patents
• Biotech Cos. Battle Over Forum In Stem Cells Suit